Class information for:
Level 1: BRIDGING STUDY//MULTIREGIONAL CLINICAL TRIAL//MULTIREGIONAL TRIAL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
16733 574 22.9 55%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
970 10197 CAUSAL INFERENCE//PRINCIPAL STRATIFICATION//STATISTICS IN MEDICINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BRIDGING STUDY Author keyword 16 54% 3% 20
2 MULTIREGIONAL CLINICAL TRIAL Author keyword 15 77% 2% 10
3 MULTIREGIONAL TRIAL Author keyword 15 88% 1% 7
4 CONSISTENT TREND Author keyword 11 100% 1% 6
5 COVARIATE ADJUSTMENT Author keyword 10 32% 5% 27
6 ETHNIC EFFECT Author keyword 6 80% 1% 4
7 MULTIREGIONAL CLINICAL TRIALS Author keyword 6 80% 1% 4
8 REGIONAL SAMPLE SIZE Author keyword 6 100% 1% 4
9 SUBJECT TREATMENT INTERACTION Author keyword 6 100% 1% 4
10 SUBGROUP ANALYSES Author keyword 5 34% 2% 11

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 BRIDGING STUDY 16 54% 3% 20 Search BRIDGING+STUDY Search BRIDGING+STUDY
2 MULTIREGIONAL CLINICAL TRIAL 15 77% 2% 10 Search MULTIREGIONAL+CLINICAL+TRIAL Search MULTIREGIONAL+CLINICAL+TRIAL
3 MULTIREGIONAL TRIAL 15 88% 1% 7 Search MULTIREGIONAL+TRIAL Search MULTIREGIONAL+TRIAL
4 CONSISTENT TREND 11 100% 1% 6 Search CONSISTENT+TREND Search CONSISTENT+TREND
5 COVARIATE ADJUSTMENT 10 32% 5% 27 Search COVARIATE+ADJUSTMENT Search COVARIATE+ADJUSTMENT
6 ETHNIC EFFECT 6 80% 1% 4 Search ETHNIC+EFFECT Search ETHNIC+EFFECT
7 MULTIREGIONAL CLINICAL TRIALS 6 80% 1% 4 Search MULTIREGIONAL+CLINICAL+TRIALS Search MULTIREGIONAL+CLINICAL+TRIALS
8 REGIONAL SAMPLE SIZE 6 100% 1% 4 Search REGIONAL+SAMPLE+SIZE Search REGIONAL+SAMPLE+SIZE
9 SUBJECT TREATMENT INTERACTION 6 100% 1% 4 Search SUBJECT+TREATMENT+INTERACTION Search SUBJECT+TREATMENT+INTERACTION
10 SUBGROUP ANALYSES 5 34% 2% 11 Search SUBGROUP+ANALYSES Search SUBGROUP+ANALYSES

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MULTIREGIONAL TRIAL 15 82% 2% 9
2 PATIENT SUBSETS 12 75% 2% 9
3 COVARIATE ADJUSTMENT 6 26% 3% 20
4 REGRESSION ADJUSTMENTS 3 45% 1% 5
5 SUBSET ANALYSIS 3 35% 1% 7
6 CATEGORICAL DATA ANALYSIS 2 36% 1% 5
7 COVARIATE IMBALANCE 2 67% 0% 2
8 QUALITATIVE INTERACTIONS 2 30% 1% 6
9 PRETEST POSTTEST 2 50% 1% 3
10 REGISTRATION PURPOSES 2 43% 1% 3

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
How to Use a Subgroup Analysis 2014 30 20 30%
The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review 2011 15 28 36%
A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research 2013 8 17 35%
Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review 2010 17 24 46%
Multicentre trials: a US regulatory perspective 2005 21 9 67%
Secondary Analysis of Clinical Trials-A Cautionary Note 2012 2 6 50%
Randomization-based nonparametric methods for the analysis of multicentre trials 2005 14 8 75%
Primer: the fallacy of subgroup analysis 2007 17 15 53%
Assessing consistent treatment effect in a multi-regional clinical trial: a systematic review 2010 6 17 53%
Treating Individuals 2 - Subgroup analysis in randomised controlled trials: importance, indications, and interpretation 2005 300 92 10%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CLIN TRIAL STAT 2 38% 0.9% 5
2 DRUG DEV REGULATORY SCI PHARM 1 100% 0.3% 2
3 OB OTS CDER DB1 1 100% 0.3% 2
4 SUNNYBROOK WOMENS UNIT 1 100% 0.3% 2
5 ASIA PACIFIC STAT SCI 1 21% 0.5% 3
6 BIOMETR CONSULTING 1 50% 0.2% 1
7 CARDIOL MED CLIN OUTCOMES EDUC 1 50% 0.2% 1
8 CLIN PHARMACOL CONSULTAT UNIT 1 50% 0.2% 1
9 CLIN PROGRAM MANAGEMENT 1 50% 0.2% 1
10 ENREGISTREMENT ETUDES CLIN 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000255446 ADAPTIVE TREATMENT STRATEGIES//DYNAMIC TREATMENT REGIME//DYNAMIC TREATMENT REGIMES
2 0.0000177590 NON INFERIORITY MARGIN//NON INFERIORITY//THREE ARM DESIGN
3 0.0000153855 RESPONSE ADAPTIVE DESIGN//DOUBLY ADAPTIVE BIASED COIN DESIGN//RESPONSE ADAPTIVE DESIGNS
4 0.0000133714 WORST RANK SCORES//REPRODUCIBILITY PROBABILITY//BOUNDED OUTCOME SCORES
5 0.0000120219 INTERACTION CONDITION//TARGETED CLINICAL TRIALS//INFLUENCE CONDITION
6 0.0000119122 NONHOMOGENEOUS REGRESSION//EXACT STATISTICS//ADJUSTED MEANS
7 0.0000118201 CLUSTER RANDOMIZED TRIALS//CLUSTER RANDOMIZATION//GROUP RANDOMIZED TRIALS
8 0.0000094531 CHANGE TO OPEN LABEL DESIGN//HPV TRIAGE TESTING//CLIENT VARIABLES
9 0.0000088710 CAUSAL INFERENCE//PRINCIPAL STRATIFICATION//TARGETED MAXIMUM LIKELIHOOD ESTIMATION
10 0.0000087465 MULTIPLE INFERENCES//STEP WISE PROCEDURES//SIR FRANCES GALTON